Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain in extremity, Parosmia, SARS-CoV-2 test, Somnolence
Clinical narrative: Sleep; Chills; lightheaded; tired; cold; headache started; arm pain at injection site; sweating heavily; Chemical smells lasted 5-10minutes; left arm was sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 03Jun2021 15:15 (Lot number: EW0150) at the age of 32 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Migraines" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "COVID-19", start date: 19Dec2020 (unspecified if ongoing); "Obese" (unspecified if ongoing); "Allergy to peanuts" (unspecified if ongoing). Concomitant medication(s) included: DUONEB; BENZONATATE; BREO ELLIPTA; SPIRIVA RESPIMAT; OMEPRAZOLE; ALBUTEROL SULFATE; MONTELUKAST; ALBUTEROL [SALBUTAMOL]; VITAMIN D3; ZINC; VIT C; VITAMIN E [TOCOPHEROL]; CETIRIZINE. Past drug history included: Sulfa, reaction(s): "Allergy"; Citalopram, reaction(s): "Allergy". The following information was reported: PAROSMIA (non-serious) with onset 03Jun2021 15:55, outcome "recovered" (Jun2021), described as "Chemical smells lasted 5-10minutes"; HYPERHIDROSIS (non-serious) with onset 03Jun2021 16:00, outcome "recovered" (Jun2021), described as "sweating heavily"; VACCINATION SITE PAIN (non-serious) with onset 03Jun2021 18:00, outcome "not recovered", described as "arm pain at injection site"; HEADACHE (non-serious) with onset 03Jun2021 18:10, outcome "recovered" (Jun2021), described as "headache started"; DIZZINESS (non-serious) with onset 03Jun2021 18:40, outcome "recovered" (Jun2021), described as "lightheaded"; FATIGUE (non-serious) with onset 03Jun2021 18:40, outcome "not recovered", described as "tired"; NASOPHARYNGITIS (non-serious) with onset 03Jun2021 18:40, outcome "recovered" (Jun2021), described as "cold"; CHILLS (non-serious) with onset 03Jun2021 19:45, outcome "recovered" (Jun2021), described as "Chills"; SOMNOLENCE (non-serious) with onset 03Jun2021 20:00, outcome "recovered" (Jun2021), described as "Sleep"; PAIN IN EXTREMITY (non-serious) with onset Jun2021, outcome "not recovered", described as "left arm was sore". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of parosmia, hyperhidrosis, headache, dizziness, fatigue, nasopharyngitis, chills, somnolence. Therapeutic measures were taken as a result of vaccination site pain.  Additional information: Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination was reported as yes. Duo-Neb, Benzonatate 200mg, Breo Ellipta 200-25 mcg/dose inhaler, Spiriva Respimat 2.5 mcg/actuation, Omeprazole 20MG capsule, Albuterol Sulfate 90 mcg inhaler, monteluskast 10mg tablet, Albuterol 2.5/3mL nebulizer solution, Vitamin D3, Zinc, Vitamin C, Vitamin E, Cetirizine 10 mg tablet. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient needed 400mg Ibuprofen for arm pain at injection site. Reported Event: Vaccine -3:20pm 1st dose (As reported). Adverse events start date and time was reported as 03Jun2021 (03:45PM) (As reported). At 5:00am patient felt better except tired, and the left arm was sore, all other side effects were gone. Reported as Non-serious.  Follow-up attempts are completed. No further information is expected.